Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic
Completed · Phase 4
Conditions studied: Renal Transplantation
In brief
The purpose of this study is to determine whether the combination of Myfortic and sirolimus is effective at preventing rejection while preserving kidney function in stable kidney transplant recipients.
Key facts
- Study ID
- NCT00713284
- Run by
- California Pacific Medical Center Research Institute
- People needed
- 29
- Starts
- 2007-05-01
- Expected to finish
- 2010-11-01
- Last updated by the study team
- 2020-10-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- California Pacific Medical Center; Barry S. Levin, MD Department of Transplantation — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.